| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Can Prognostic Factors Be Used to Direct Therapy in Chronic Lymphocytic Leukemia?
|
Sellner, Leopold
|
|
2011
|
7 |
1 |
p. 3-12
|
article
|
| 2 |
Disordered Epigenetic Regulation in the Pathophysiology of Myeloproliferative Neoplasms
|
Zhang, Su-Jiang
|
|
2011
|
7 |
1 |
p. 34-42
|
article
|
| 3 |
Immune Reconstitution in Chronic Lymphocytic Leukemia
|
Riches, John C.
|
|
2011
|
7 |
1 |
p. 13-20
|
article
|
| 4 |
Immune Reconstitution in Chronic Lymphocytic Leukemia
|
Riches, John C.
|
|
|
7 |
1 |
p. 13-20
|
article
|
| 5 |
Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
|
Burger, Jan A.
|
|
2011
|
7 |
1 |
p. 26-33
|
article
|
| 6 |
Lessons from ALL-REZ BFM 90: Therapy for Childhood Leukemia Based on Timing and Site of Relapse
|
Rytting, Michael E.
|
|
2012
|
7 |
1 |
p. 1-2
|
article
|
| 7 |
Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice
|
Barosi, Giovanni
|
|
2012
|
7 |
1 |
p. 50-56
|
article
|
| 8 |
Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?
|
Feldman, E. J.
|
|
2011
|
7 |
1 |
p. 74-77
|
article
|
| 9 |
Prognostication in Primary Myelofibrosis
|
Cervantes, Francisco
|
|
2011
|
7 |
1 |
p. 43-49
|
article
|
| 10 |
Role of TET2 Mutations in Myeloproliferative Neoplasms
|
Pronier, Elodie
|
|
2011
|
7 |
1 |
p. 57-64
|
article
|
| 11 |
Transformation of a Chronic Myeloproliferative Neoplasm to Acute Myelogenous Leukemia: Does Anything Work?
|
Kundranda, Madappa N.
|
|
2011
|
7 |
1 |
p. 78-86
|
article
|
| 12 |
Treatment of Older Patients with Chronic Lymphocytic Leukemia
|
Lamanna, Nicole
|
|
2012
|
7 |
1 |
p. 21-25
|
article
|
| 13 |
What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
|
Jurcic, Joseph G.
|
|
2011
|
7 |
1 |
p. 65-73
|
article
|
Journal description